Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Retina > Alternative management for post-cataract endophthalmitis shows promising results
  • Retina

Alternative management for post-cataract endophthalmitis shows promising results

Kelsey Moroz

Managing post-cataract surgery endophthalmitis without performing microbial cultures results in similar visual outcomes to cases managed with cultures and may reduce the incidence of secondary retinal detachments, according to a study.

The retrospective, single-center comparative cohort study evaluated 232 cases of endophthalmitis following cataract surgery. Cases were divided into 2 groups: a “culture group” (n = 196 eyes) where vitreous or aqueous specimens were sent for microbiologic sampling, and a “no culture group” (n = 36 eyes) where specimens were not sent for sampling.

The study found no significant difference in visual acuity (VA) at presentation between the groups, with the culture group having a mean logMAR VA of 2.14 (20/2760) and the no culture group having a mean logMAR VA of 1.93 (20/1702). At the 12-month follow-up, the culture group had a mean logMAR VA of 0.80 (20/126) compared to 0.41 (20/50) in the no culture group, a difference that was not statistically significant (P = 0.076).

The incidence of retinal detachment was higher in the culture group, with 10% of eyes developing secondary retinal detachments within 12 months, compared to none in the no culture group (P = 0.045).

Reference
Samuelson AG, Patel SN, Kommareddy K, Momenaei B, Yu-Chuan Kang E, Chaudhary V, Hsu J, Dunn JP, Vander JF, Garg SJ. Outcomes of Post-Cataract Surgery Endophthalmitis Managed Without Microbial Cultures. Ophthalmol Retina. 2024;S2468-6530(24)00338-5. doi: 10.1016/j.oret.2024.07.015. Epub ahead of print. PMID: 39038541.

Share

Related Content

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

  • Retina

Aflibercept 8 mg demonstrates favorable safety profile in large nAMD cohort

  • Retina

Aflibercept 8 mg shows modest benefits in difficult-to-treat nAMD cases

  • Retina

AXPAXLI meets superiority endpoint in SOL-1 Phase 3 wet AMD trial

  • Diabetic Macular Edema

Hawaiian Eye Meeting update: TKI therapy may reduce treatment burden in DME and wet AMD

  • Retina

Metformin linked to lower incidence of intermediate AMD in patients with diabetes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon